{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:26:57Z","timestamp":1648553217320},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1007\/s00108-006-1587-x","type":"journal-article","created":{"date-parts":[[2006,3,21]],"date-time":"2006-03-21T09:23:53Z","timestamp":1142933033000},"page":"389-401","source":"Crossref","is-referenced-by-count":3,"title":["Zielgerichtete Kreislauftherapie"],"prefix":"10.1007","volume":"47","author":[{"given":"S.","family":"Kluge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kreymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1587_CR1","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa050935","volume":"353","author":"Abraham","year":"2005","unstructured":"Abraham E, Laterre PF, Garg R et al. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353: 1332\u20131341","journal-title":"N Engl J Med"},{"key":"1587_CR2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00390-005-0575-z","volume":"42","author":"Adams","year":"2005","unstructured":"Adams HA, Baumann G, Cascorbi I et al. (2005) Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI \u2013 Teil 2: Hypovol\u00e4mischer Schock. Intensivmedizin 42: 96\u2013109","journal-title":"Intensivmedizin"},{"key":"1587_CR3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00390-005-0577-x","volume":"42","author":"Adams","year":"2005","unstructured":"Adams HA, Baumann G, Cascorbi I et al. (2005) Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI \u2013 Teil 4: Anaphylaktischer Schock. Intensivmed 42: 299\u2013304","journal-title":"Intensivmed"},{"key":"1587_CR4","unstructured":"Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst RevCD001090"},{"key":"1587_CR5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699\u2013709","journal-title":"N Engl J Med"},{"key":"1587_CR6","doi-asserted-by":"crossref","unstructured":"Bunn F, Roberts I, Tasker R, Akpa E (2004) Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst RevCD002045","DOI":"10.1002\/14651858.CD002045.pub2"},{"key":"1587_CR7","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/bmj.317.7153.235","volume":"317","author":"Cochrane","year":"1998","unstructured":"Cochrane Injuries Group Albumin Reviewers (1998) Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317: 235\u2013240","journal-title":"BMJ"},{"key":"1587_CR8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","volume":"32","author":"Dellinger","year":"2004","unstructured":"Dellinger RP, Carlet JM, Masur H et al. (2004) Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858\u2013873","journal-title":"Crit Care Med"},{"key":"1587_CR9","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000066692.71008.BB","volume":"107","author":"Dunser","year":"2003","unstructured":"Dunser MW, Mayr AJ, Ulmer H et al. (2003) Arginine vasopressin in advanced vasodilatory shock: a prospective, randomized, controlled study. Circulation 107: 2313\u20132319","journal-title":"Circulation"},{"key":"1587_CR10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00005373-200206000-00020","volume":"52","author":"Dutton","year":"2002","unstructured":"Dutton RP, Mackenzie CF, Scalea TM (2002) Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma 52: 1141\u20131146","journal-title":"J Trauma"},{"key":"1587_CR11","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1053\/euhj.2001.2782","volume":"22","author":"Erbel","year":"2001","unstructured":"Erbel R, Alfonso F, Boileau C et al. (2001) Diagnosis and management of aortic dissection. Eur Heart J 22: 1642\u20131681","journal-title":"Eur Heart J"},{"key":"1587_CR12","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","volume":"350","author":"Finfer","year":"2004","unstructured":"Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350: 2247\u20132256","journal-title":"N Engl J Med"},{"key":"1587_CR13","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1097\/00003246-199812000-00045","volume":"26","author":"Friedman","year":"1998","unstructured":"Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26: 2078\u20132086","journal-title":"Crit Care Med"},{"key":"1587_CR14","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0735-1097(00)00879-2","volume":"36","author":"Hochman","year":"2000","unstructured":"Hochman JS, Buller CE, Sleeper LA et al. (2000) Cardiogenic shock complicating acute myocardial infarction \u2013 etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK? J Am Coll Cardiol 36: 1063\u20131070","journal-title":"J Am Coll Cardiol"},{"key":"1587_CR15","first-page":"673","volume":"35","author":"Janssens","year":"1994","unstructured":"Janssens U, Hanrath P (1994) Schock. Internist 35: 673\u2013689","journal-title":"Internist"},{"key":"1587_CR16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/00003246-200208000-00002","volume":"30","author":"Kern","year":"2002","unstructured":"Kern JW, Shoemaker WC (2002) Meta-analysis of hemodynamic optimization in high-risk patients. Crit Care Med 30: 1686\u20131692","journal-title":"Crit Care Med"},{"key":"1587_CR17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00101-002-0398-2","volume":"51","author":"Kreimeier","year":"2002","unstructured":"Kreimeier U, Lackner CK, Pruckner S, Ruppert M, Peter K (2002) Permissive Hypotension beim schweren Trauma. Anaesthesist 51: 787\u2013799","journal-title":"Anaesthesist"},{"key":"1587_CR18","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s00101-004-0793-y","volume":"54","author":"Krismer","year":"2005","unstructured":"Krismer AC, Wenzel V, Voelckel WG et al. (2005) Employing vasopressin as an adjunct vasopressor in uncontrolled traumatic hemorrhagic shock. Three cases and a brief analysis of the literature. Anaesthesist 54: 220\u2013224","journal-title":"Anaesthesist"},{"key":"1587_CR19","doi-asserted-by":"crossref","unstructured":"Kwan I, Bunn F, Roberts I (2003) Timing and volume of fluid administration for patients with bleeding. Cochrane Database Syst RevCD002245","DOI":"10.1002\/14651858.CD002245"},{"key":"1587_CR20","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1097\/01.CCM.0000186749.34028.40","volume":"33","author":"Luckner","year":"2005","unstructured":"Luckner G, Dunser MW, Jochberger S et al. (2005) Arginine vasopressin in 316 patients with advanced vasodilatory shock. Crit Care Med 33: 2659\u20132666","journal-title":"Crit Care Med"},{"key":"1587_CR21","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","volume":"345","author":"Rivers","year":"2001","unstructured":"Rivers E, Nguyen B, Havstad S et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345: 1368\u20131377","journal-title":"N Engl J Med"},{"key":"1587_CR22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0883-9441(99)90018-7","volume":"14","author":"Sakka","year":"1999","unstructured":"Sakka SG, Bredle DL, Reinhart K, Meier-Hellmann A (1999) Comparison between intrathoracic blood volume and cardiac filling pressures in the early phase of hemodynamic instability of patients with sepsis or septic shock. J Crit Care 14: 78\u201383","journal-title":"J Crit Care"},{"key":"1587_CR23","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s00134-004-2415-1","volume":"30","author":"Schortgen","year":"2004","unstructured":"Schortgen F, Deye N, Brochard L (2004) Preferred plasma volume expanders for critically ill patients: results of an international survey. Intensive Care Med 30: 2222\u20132229","journal-title":"Intensive Care Med"},{"key":"1587_CR24","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-2004-817674","volume":"39","author":"Suttner","year":"2004","unstructured":"Suttner S, Boldt J (2004) Beeinflu\u00dft die Gabe von Hydroxyethylst\u00e4rke die Nierenfunktion? Anasthesiol Intensivmed Notfallmed Schmerzther 39: 71\u201377","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"1587_CR25","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00101-004-0771-4","volume":"53","author":"Voelckel","year":"2004","unstructured":"Voelckel WG, von GA, Fries D, Krismer AC, Wenzel V, Lindner KH (2004) Die Behandlung des h\u00e4morrhagischen Schocks. Neue Therapieoptionen. Anaesthesist 53: 1151\u20131167","journal-title":"Anaesthesist"},{"key":"1587_CR26","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-135-3-200108070-00007","volume":"135","author":"Wilkes","year":"2001","unstructured":"Wilkes MM, Navickis RJ (2001) Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 135: 149\u2013164","journal-title":"Ann Intern Med"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1587-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-006-1587-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-006-1587-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T00:11:35Z","timestamp":1558570295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-006-1587-x"}},"subtitle":["Schockbehandlung in Notarztwagen, Notaufnahme und Intensivstation"],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["1587"],"URL":"https:\/\/doi.org\/10.1007\/s00108-006-1587-x","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}